Follow
Robert E. W. Hancock
Title
Cited by
Cited by
Year
Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances
I Wiegand, K Hilpert, REW Hancock
Nature protocols 3 (2), 163-175, 2008
59532008
Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic pathogen
CK Stover, XQ Pham, AL Erwin, SD Mizoguchi, P Warrener, MJ Hickey, ...
Nature 406 (6799), 959-964, 2000
55512000
Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies
REW Hancock, HG Sahl
Nature biotechnology 24 (12), 1551-1557, 2006
45652006
Peptide antimicrobial agents
H Jenssen, P Hamill, REW Hancock
Clinical microbiology reviews 19 (3), 491-511, 2006
32122006
Designing antimicrobial peptides: form follows function
CD Fjell, JA Hiss, REW Hancock, G Schneider
Nature reviews Drug discovery 11 (1), 37-51, 2012
20092012
Peptide antibiotics
REW Hancock, DS Chapple
Antimicrobial agents and chemotherapy 43 (6), 1317-1323, 1999
20001999
Cationic peptides: a new source of antibiotics
REW Hancock, R Lehrer
Trends in biotechnology 16 (2), 82-88, 1998
19391998
Peptide antibiotics
REW Hancock
The lancet 349 (9049), 418-422, 1997
17881997
The role of cationic antimicrobial peptides in innate host defences
REW Hancock, G Diamond
Trends in microbiology 8 (9), 402-410, 2000
17102000
Pseudomonas aeruginosa : new insights into pathogenesis and host defenses
SL Gellatly, REW Hancock
Pathogens and disease 67 (3), 159-173, 2013
15112013
Pseudomonas aeruginosa: all roads lead to resistance
EBM Breidenstein, C de la Fuente-Núñez, REW Hancock
Trends in microbiology 19 (8), 419-426, 2011
14302011
Cationic peptides: effectors in innate immunity and novel antimicrobials
REW Hancock
The Lancet infectious diseases 1 (3), 156-164, 2001
13482001
The role of antimicrobial peptides in animal defenses
REW Hancock, MG Scott
Proceedings of the national Academy of Sciences 97 (16), 8856-8861, 2000
13222000
Antibacterial peptides for therapeutic use: obstacles and realistic outlook
AK Marr, WJ Gooderham, REW Hancock
Current opinion in pharmacology 6 (5), 468-472, 2006
13112006
NetworkAnalyst 3.0: a visual analytics platform for comprehensive gene expression profiling and meta-analysis
G Zhou, O Soufan, J Ewald, REW Hancock, N Basu, J Xia
Nucleic acids research 47 (W1), W234-W241, 2019
12842019
The relationship between peptide structure and antibacterial activity
JPS Powers, REW Hancock
Peptides 24 (11), 1681-1691, 2003
12032003
InnateDB: systems biology of innate immunity and beyond—recent updates and continuing curation
K Breuer, AK Foroushani, MR Laird, C Chen, A Sribnaia, R Lo, GL Winsor, ...
Nucleic acids research 41 (D1), D1228-D1233, 2013
11662013
Cationic host defense (antimicrobial) peptides
KL Brown, REW Hancock
Current opinion in immunology 18 (1), 24-30, 2006
10532006
Adaptive and mutational resistance: role of porins and efflux pumps in drug resistance
L Fernández, REW Hancock
Clinical microbiology reviews 25 (4), 661-681, 2012
10072012
Resistance Mechanisms in Pseudomonas aeruginosa and Other Nonfermentative Gram-Negative Bacteria
REW Hancock
Clinical Infectious Diseases 27 (Supplement_1), S93-S99, 1998
10001998
The system can't perform the operation now. Try again later.
Articles 1–20